Pharmalucence builds radiopharma facility; Ghana anti-counterfeiting system connectivity a "go;"

> Radiopharmaceuticals maker Pharmalucence is replacing and modernizing its manufacturing infrastructure by building a 70,000 square foot production facility in Billerica, MA. Release

> The first phase is underway of an mPedigree system in Ghana, reported earlier, in which consumers text scratch codes via cell phone to verify drug authenticity: A test has demonstrated connectivity with the Hewlett-Packard data center. Article

> Third-party logistics provider DRS Group of Hyderabad has launched the DRS Labs contract manufacturing division by unveiling a 40,000-square-foot facility for the production of tablets, capsules, liquids and ointments. Article

> Virtify, maker of the Enterprise Content Compliance software, has been named to Gartner's list of "Cool Vendors in Life Sciences." Release

> KV Pharmaceutical has finally closed on the sale of its raw-material and drug-making subsidiary Particle Dynamics to an investor group, five years after a fire delayed the transaction. Article

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)